SIBNライブシグナル | Getagraph.comで利益を最大化

買う 107773 min ago

@ $20.55

発行日: 15 2月 2024 @ 05:28

リターン: -27.86%

前回のシグナル: 2月 14 - 23:30

前回のシグナル: 売る

リターン: -2.70 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:41):

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally...

Stats
本日の出来高	83 444.00
平均出来高	427 456
時価総額	608.78M
EPS	$0 ( 2024-02-26 )
次の収益日	( $-0.290 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.12
ATR14	$0.0160 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Recupero Anthony J	Sell	1 555	Common Stock
2024-04-02	Recupero Anthony J	Sell	1 752	Common Stock
2024-04-03	Recupero Anthony J	Sell	920	Common Stock
2024-04-02	Maheshwari Anshul	Sell	1 140	Common Stock
2024-04-02	Maheshwari Anshul	Sell	1 285	Common Stock

INSIDER POWER
20.99
Last 100 transactions
Buy: 453 308 \| Sell: 383 933

ボリューム相関

長: 0.01 (neutral)

短: 0.90 (strong)

Signal:(53.224) Same movement expected

SI-BONE Inc 相関

10 最も正の相関
PAIC	0.926
SVOK	0.925
SVAC	0.885
XOG	0.885
TRIN	0.881
FORE	0.881
KZIA	0.864
RDUS	0.861
OTTR	0.856
HJLI	0.848

10 最も負の相関
NETE	-0.936
RAVN	-0.904
HRMY	-0.902
CFMS	-0.9
SFST	-0.878
BOCH	-0.875
AMRB	-0.875
RPTX	-0.872
MYFW	-0.852
MMAC	-0.85

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

SI-BONE Inc 相関 - 通貨/商品

0.40
( neutral )

0.25
( neutral )

0.00
( neutral )

0.24
( neutral )

0.60
( weak )

-0.04
( neutral )

SI-BONE Inc 財務諸表

Annual	2023
収益:	$138.89M
総利益:	$109.42M (78.78 %)
EPS:	$-1.130

FY	2023
収益:	$138.89M
総利益:	$109.42M (78.78 %)
EPS:	$-1.130

FY	2022
収益:	$106.41M
総利益:	$90.70M (85.24 %)
EPS:	$-1.840

FY	2021
収益:	$90.15M
総利益:	$79.72M (88.43 %)
EPS:	$-1.697

Financial Reports:

No articles found.

SI-BONE Inc

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.